Literature DB >> 3942283

The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up.

M B Keller, P W Lavori, J Rice, W Coryell, R M Hirschfeld.   

Abstract

The authors report on the course of illness in 101 patients who were in an episode (the "index episode") of major depressive disorder when they entered a clinical research study, recovered from that episode, and then relapsed into a new episode (the "first prospective episode") of the disorder. They found a 22% probability that these patients' first prospective episode would last at least 1 year, similar to the 21% rate of chronicity previously reported for the index episode. A long prior episode, older age, and low family income were found to predict chronicity in the first prospective episode.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942283     DOI: 10.1176/ajp.143.1.24

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  22 in total

1.  Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study.

Authors:  Tomislav Kovačević; Ivan Skelin; Luciano Minuzzi; Pedro Rosa-Neto; Mirko Diksic
Journal:  Brain Res Bull       Date:  2012-01-31       Impact factor: 4.077

2.  The prediction of recovery using a multivariate model in 1471 depressed inpatients.

Authors:  D W Black; R B Goldstein; A Nasrallah; G Winokur
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  The pharmacological management of depression.

Authors:  R T Joffe
Journal:  Can Fam Physician       Date:  1986-06       Impact factor: 3.275

4.  A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder.

Authors:  M F de Mello; L M Myczcowisk; P R Menezes
Journal:  J Psychother Pract Res       Date:  2001

Review 5.  Refractory depression: treatment strategies, with particular reference to the thyroid axis.

Authors:  R T Joffe
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

Review 6.  Paroxetine: a review.

Authors:  M Bourin; P Chue; Y Guillon
Journal:  CNS Drug Rev       Date:  2001

7.  Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon.

Authors:  Brian W Pence; Bradley N Gaynes; Julius Atashili; Julie K O'Donnell; Dmitry Kats; Kathryn Whetten; Alfred K Njamnshi; Tabenyang Mbu; Charles Kefie; Shantal Asanji; Peter Ndumbe
Journal:  AIDS Behav       Date:  2014-06

Review 8.  Managing resistant depression. When patients do not respond to therapy.

Authors:  L Warneke
Journal:  Can Fam Physician       Date:  1993-04       Impact factor: 3.275

9.  A clinical study of chronic depression.

Authors:  S Singhal; S Kumar; A K Agarwal
Journal:  Indian J Psychiatry       Date:  1991-10       Impact factor: 1.759

Review 10.  Mood disorders and substance use disorder: a complex comorbidity.

Authors:  Susan B Quello; Kathleen T Brady; Susan C Sonne
Journal:  Sci Pract Perspect       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.